Analyst Reco. The Beauty Health Company

Equities

SKIN

US88331L1089

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
1.92 ^USD	+1.05%		+7.26%	-38.26%

05-09	The Beauty Health Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-09	(SKIN) THE BEAUTY HEALTH COMPANY Forecasts Q2 Revenue Range $96M - $102M	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Canaccord Genuity Adjusts Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	03-14	MT
Stifel Raises Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	03-13	MT
TD Cowen Adjusts Price Target on The Beauty Health to $4 From $2.50, Maintains Market Perform Rating	03-13	MT
Piper Sandler Adjusts Beauty Health's Price Target to $3 From $2, Maintains Underweight Rating	03-13	MT
Jefferies Downgrades Beauty Health to Hold From Buy, Adjusts Price Target to $1.50 From $11	11-15	MT
Stifel Adjusts Beauty Health's Price Target to $3 From $8, Keeps Hold Rating	11-14	MT
TD Cowen Downgrades Beauty Health to Market Perform From Outperform, Cuts Price Target to $2.50 From $9	11-14	MT
Raymond James Downgrades Beauty Health to Underperform From Market Perform	11-14	MT
William Blair Downgrades Beauty Health to Market Perform From Outperform	11-14	MT
Canaccord Genuity Downgrades Beauty Health to Hold From Buy, Price Target is $2.50	11-14	MT
JPMorgan Downgrades Beauty Health to Underweight From Neutral	11-14	MT
Piper Sandler Downgrades Beauty Health to Underweight From Overweight, Adjusts Price Target to $2 From $12	11-14	MT
Canaccord Genuity Assumes The Beauty Health Company at Buy With $10 Price Target	23-08-25	MT
TD Cowen Adjusts Price Target on The Beauty Health to $9 From $15, Maintains Outperform Rating	23-08-10	MT
DA Davidson Adjusts Price Target on Beauty Health to $16.50 From $35, Maintains Buy Rating	23-08-10	MT
Stifel Downgrades The Beauty Health Company to Hold From Buy, Adjusts Price Target to $10 From $17	23-06-21	MT
JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating	23-05-26	MT
BNP Paribas Exane Upgrades The Beauty Health to Neutral From Underperform	23-03-20	MT
DA Davidson Adjusts Price Target on Beauty Health to $35 From $32, Keeps Buy Rating	23-03-01	MT
Piper Sandler Adjusts The Beauty Health Price Target to $16 From $15, Maintains Overweight Rating	23-02-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. The Beauty Health Company

Equities

SKIN

US88331L1089

Analyst Reco.

Filters